Diabetes Care, Vol 21, Issue 8 1306-1309, Copyright © 1998 by American Diabetes Association

ARTICLES

Diabetic nephropathy in hypertransfused patients with beta-thalassemia. The role of oxidative stress

R Loebstein, DC Lehotay, X Luo, W Bartfay, B Tyler and GD Sher
Division of Clinical Pharmacology and Toxicology, Hospital for Sick Children, Toronto, Ontario, Canada.

OBJECTIVE: Pathogenesis of diabetes-related microvascular complications involving oxidative damage by free radicals has been demonstrated. Free radical generation has been shown to derive largely from iron. Our objectives, therefore, were to determine if there is an increased incidence and/or an accelerated course of nephropathy in patients with diabetes, secondary to transfusional hemochromatosis, and to examine whether free radical activity contributes to the development of this complication. RESEARCH DESIGN AND METHODS: We evaluated nine patients with homozygous beta-thalassemia, complicated by clinically overt diabetes, for diabetic nephropathy over a 7-year period. Lipid peroxidation was quantified by measuring the presence of 20 saturated and unsaturated aldehydes, and results were compared with five normotensive type 1 diabetic patients without iron overload. RESULTS: Nephropathy developed in five of nine patients (55%) after a mean duration of overt diabetes of 3.6 +/- 2.0 years. Three patients showed evidence of progressive microalbuminuria over a 7-year period (24.7-46.2, 52.2-430.1, and 17.7-54.3 micrograms/min, respectively). Two patients with borderline microalbuminuria (19.9 and 14.5 micrograms/min, respectively) demonstrated stable albumin excretion rates over the follow-up period. Total aldehyde concentration was significantly higher in beta-thalassemia diabetic patients, compared with nonthalassemic diabetic control subjects (8,106 +/- 1,280 vs. 4,594 +/- 247 nmol/l; P < 0.0001). The three patients with progressive microalbuminuria demonstrated significantly higher total aldehyde concentration, compared with the other beta-thalassemia diabetic patients with stable albumin excretion (9,428 +/- 337 vs. 7,445 +/- 1,003 nmol/l; P < 0.01). Serum vitamin E concentrations were significantly lower in beta-thalassemia patients with diabetes, compared with diabetic patients without iron overload (12.1 +/- 6.0 vs. 25.9 +/- 11.4 mumol/l; P = 0.02). Serum vitamin C concentrations did not differ between the two groups. Multiple regression analysis demonstrated total aldehyde concentration to be the most significant predictor for the development of microalbuminuria (P = 0.01), followed by the duration of diabetes (P = 0.02) and glycemic control (P = 0.02). CONCLUSIONS: Early development and an accelerated course of diabetic nephropathy in iron-loaded patients with beta-thalassemia are observed. These findings may be attributed to high oxidative stress in these patients, which is secondary to iron-derived free radicals and to the patients' diminished antioxidant reserves.
CiteULike    Del.icio.us    Digg    Reddit    Technorati    What's this?

This article has been cited by other articles:

				T. M.E. Davis, J. Beilby, W. A. Davis, J. K. Olynyk, G. P. Jeffrey, E. Rossi, C. Boyder, and D. G. Bruce Prevalence, Characteristics, and Prognostic Significance of HFE Gene Mutations in Type 2 Diabetes: The Fremantle Diabetes Study Diabetes Care, September 1, 2008; 31(9): 1795 - 1801. [Abstract] [Full Text] [PDF]

				S. Swaminathan, V. A. Fonseca, M. G. Alam, and S. V. Shah The Role of Iron in Diabetes and Its Complications Diabetes Care, July 1, 2007; 30(7): 1926 - 1933. [Full Text] [PDF]

				M Kadkhodaee and A Gol The role of nitric oxide in iron-induced rat renal injury Human and Experimental Toxicology, November 1, 2004; 23(11): 533 - 536. [Abstract] [PDF]

				J. C.N. Chan, N. M.S. Wat, W.-Y. So, K. S.L. Lam, C.-T. Chua, K.-S. Wong, Z. Morad, T. Z. Dickson, D. Hille, Z. Zhang, et al. Renin Angiotensin Aldosterone System Blockade and Renal Disease in Patients With Type 2 Diabetes: An Asian perspective from the RENAAL study Diabetes Care, April 1, 2004; 27(4): 874 - 879. [Abstract] [Full Text] [PDF]

				T. Kuroki, K. Isshiki, and G. L. King Oxidative Stress: The Lead or Supporting Actor in the Pathogenesis of Diabetic Complications J. Am. Soc. Nephrol., August 1, 2003; 14(90003): S216 - 220. [Full Text] [PDF]

				J. M. Fernandez-Real, A. Lopez-Bermejo, and W. Ricart Cross-Talk Between Iron Metabolism and Diabetes Diabetes, August 1, 2002; 51(8): 2348 - 2354. [Abstract] [Full Text] [PDF]

				D. K. Moczulski, W. Grzeszczak, and B. Gawlik Role of Hemochromatosis C282Y and H63D Mutations in HFE Gene in Development of Type 2 Diabetes and Diabetic Nephropathy Diabetes Care, July 1, 2001; 24(7): 1187 - 1191. [Abstract] [Full Text] [PDF]

				W. J. Bartfay and E. Bartfay Iron-Overload Cardiomyopathy: Evidence for a Free Radical- Mediated Mechanism of Injury and Dysfunction in a Murine Model Biol Res Nurs, July 1, 2000; 2(1): 49 - 59. [Abstract] [PDF]